Pharma supply-chain decision support
AI support for pharma supply-chain review
Bring shipment conditions, supply-planning signals and traceability records into a reviewable workflow. NeoBram scopes pharmaceutical supply-chain assistance around reliable source identity, explicit uncertainty and the quality or planning owner who decides the response.
Choose the decision and its accountable owner
Cold-chain investigation, shortage planning and traceability reconciliation are distinct decisions. Select one workflow, its review horizon and the consequence of a missed or false exception. A shipment flag should reach the logistics and quality people who can assess it; a supply forecast belongs with the authorized planning team. Neither is an automatic product-disposition decision.
Connect the product, batch and shipment evidence
Useful inputs may include inventory and order records, batch status, supplier updates, shipment events and authorized temperature logger data. Establish units, time zones, product identities and the relationship between a batch, shipment and recording device. Preserve original records and distinguish unavailable information from a confirmed normal condition.
- Retain sensor calibration or quality information, recording gaps and the product-specific limits approved by quality owners.
- Separate available, reserved, quarantined and released inventory where those states affect the planning decision.
- For serialization or genealogy work, preserve event identity, source, correction history and the scope of missing partner records.
Prepare excursion evidence for quality assessment
A bounded workflow can assemble a condition timeline, approved limit reference and transport context for an investigator. Separate a recorded excursion from a model estimate of future risk. Missing logger readings or uncertain device-to-shipment mapping must remain visible. Authorized quality personnel assess product impact and any quarantine, release or disposal action under the applicable procedure.
Keep forecasts and traceability exceptions provisional
Supply-risk estimates need demand, availability, lead-time and supplier assumptions at the chosen horizon. Show which inputs are incomplete and compare with the current planning method. Traceability analytics may surface inconsistent or missing events for investigation, but an anomaly does not prove diversion, counterfeiting or recall scope. Regulatory notifications and allocation decisions require authorized review.
Evaluate each workflow on representative evidence
For excursion review, compare detected exceptions with quality-reviewed cases and test sensor gaps, timing errors and incorrect shipment mapping. For forecasting, use held-out time periods and report missed shortages, false escalations and bias by product or horizon. Test traceability reconciliation separately against reviewed event chains. A successful result in one task does not validate the others.
Agree the investigation and planning evidence pack
Possible outputs include a source-linked shipment timeline, supply-exception queue, traceability discrepancy register and evaluation findings. Define assumptions, reviewer decisions and unresolved gaps in each output. Handover covers access, retention, versioning, monitoring and change responsibilities. ERP, quality, logistics and serialization interfaces require explicit assessment; technical documentation alone does not establish regulatory compliance or validated intended use.
An illustrative cold-chain record review
A shipment includes a temperature reading outside its approved review threshold, followed by a recording gap. The workflow assembles the logger identity, timestamps, shipment record and relevant quality reference. The quality team investigates the missing evidence and decides the disposition. This example does not establish product damage, a prevented loss or a verified prediction of an excursion.
Start with one product flow and its records
Bring a recurring supply-chain question, representative records and the quality or planning owner. Agree the source boundary, error costs and acceptance criteria before proposing a model or additional interfaces. Begin with read-only evidence and reviewed recommendations. Any write-back, product disposition, external notification or wider network use requires a separately approved operating scope.
More clarity
Questions and answers
Can the system release or quarantine a shipment automatically?
Not within this initial assistance scope. Authorized quality personnel make product-disposition decisions under approved procedures using the relevant evidence, including gaps and uncertainty.
Does serialization analysis establish compliance?
No. Applicable obligations, record requirements and validation depend on the actual jurisdiction and implemented workflow. Qualified owners review the system and any resulting regulatory communication.
Can shortage forecasts work with incomplete supplier data?
A limited assessment may be possible, but missing evidence must remain visible. Useful horizon and performance are tested against the current baseline; no fixed advance warning is promised.
Will it connect to our ERP or quality platform?
Interfaces, identifiers, permissions and update behavior are scoped and tested against the actual systems. Product names or existing data exports do not establish a ready-made integration.
How should value be measured?
Measure review effort, exception quality and planning usefulness first. Inventory changes, avoided losses and service outcomes require separate evidence and should not be inferred from a model score.
Start with one business problem